Direct-to-implant breast reconstruction after neoadjuvant chemotherapy: A safe option?
CONCLUSIONS: Direct-to-implant IBR after skin-sparing mastectomy is a viable option for breast cancer patients undergoing NACT.
PMID: 31530386 [PubMed - as supplied by publisher]
Source: Cirugia eEspanola - Category: Surgery Authors: Allué Cabañuz M, Arribas Del Amo MD, Gil Romea I, Val-Carreres Rivera MP, Sousa Domínguez R, Güemes Sánchez AT Tags: Cir Esp Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Mastectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Skin | Statistics | Students | Study | Surgery | Universities & Medical Training